根据呈交香港交易所的公告，英矽智能在香港发售约9500万股股份，每股价格为24.05港元。计算显 示，该公司计划筹资约22.8亿港元（2.93亿美元）。公司预计将于12月30日挂牌上市，摩根士丹利、中 金和广发证券是联席保荐人。公司网站显示，英矽智能是一家由人工智能(AI)驱动的生物技术公司，旨 在利用其专有的Pharma.AI平台加速药物发现。 ...

海南航空客机 从美兰国际机场起飞 海口新海港和南港"二线 口岸"（货运）集中查验场。 记者 刘逸鹏 摄 ◎林铭溱 记者 刘逸鹏 海南自由贸易港，迎来了全岛封关运作的历史性时刻。 因改革开放而生，因改革开放而兴。海南正以"管得住"的底气和"放得开"的魄力，将地理意义上的"天 涯"转变为改革开放的新高地。 近日，上海证券报记者深入海南一线，感触这座热带岛屿在改革大潮中律动的强劲脉搏，聆听这片开放 新高地正在加速"蝶变"的时代声音。 产业升级 加速"蝶变" 昼夜更迭，三亚崖州湾科技城被两种"光"依次照亮——白天是北纬18度热烈的阳光，夜晚是实验室里奋 斗的灯光。 时至今日，华大集团海南区域总经理、三亚华大生命科学研究院院长岳震仍清楚记得2021年初到崖州湾 畔的情景。 "一开始，到处是工地，生活条件并不便利。我们要打造新的平台和团队，一切都需要从零起步。"岳震 感叹，时光飞逝，变化每一刻都在发生。四年来，团队人员从最初的4人发展至超过100人，与22所高校 建立实习和联合培养人才模式。现在，华大集团在崖州湾科技城内已有四处实验室，研究领域覆盖生物 育种与海洋生物制造，年投入已经超过1亿元。 海口新海客运综合枢纽 实 ...

Core Insights - The "Dongsheng Cup" International Entrepreneurship Competition concluded with Mingzhi Technology (Beijing) Co., Ltd. winning the grand prize, which includes a cash reward of 1 million yuan and support for office space and acceleration packages [1][5][7]. Group 1: Competition Overview - The competition was guided by various governmental bodies and attracted 2,061 innovative projects, marking a 23% increase from the previous year [6][13]. - A total of 340 projects received seasonal awards, with six projects advancing to the global finals [5][6]. Group 2: Winning Projects - Mingzhi Technology specializes in single-molecule protein sequencing technology, achieving over 99% accuracy in amino acid identification at a cost 5% of high-parameter mass spectrometry [9]. - Tianfu Zhiyuan Artificial Intelligence Technology Co., Ltd. developed a "digital employee" product that can significantly reduce labor costs and enhance efficiency by training AI models tailored to specific job roles [11]. Group 3: Historical Context - Since its inception in 2013, the "Dongsheng Cup" has attracted over 18,460 entrepreneurial projects from more than 100 countries, including over 3,000 overseas projects [13].

Group 1: Overview of Grid Trading Strategy - The grid trading strategy is essentially a high buy low sell trading approach, focusing on price fluctuations rather than predicting market trends, making it suitable for volatile markets [3][12] - Characteristics of suitable grid trading targets include: selecting on-market targets, stable long-term trends, low transaction costs, good liquidity, and high volatility, with equity ETFs being particularly appropriate [3][12] Group 2: Analysis of ETF Grid Strategy Targets - The military industry ETF (512710.SH) is expected to benefit from a new round of military procurement driven by the "14th Five-Year Plan" and the upcoming "15th Five-Year Plan," with China's defense budget for 2025 projected at 1.81 trillion yuan, a 7.2% increase year-on-year [3][13] - The Hang Seng Pharmaceutical ETF (159892.SZ) focuses on innovative drugs, with China's pipeline of 7,041 projects, accounting for 29.5% of the global total, and a year-on-year growth of 15.1%, indicating strong development in the pharmaceutical sector [4][16] - The Hong Kong Automotive ETF (520600.SH) is positioned to benefit from the trends of electrification and globalization in the automotive industry, with domestic sales of new energy vehicles reaching 10.929 million units, a 25.7% increase year-on-year, and exports growing by 90.4% [5][18] - The Gaming ETF (159869.SZ) is supported by the normalization of game license approvals, with 1,624 licenses issued from January to November 2025, and overseas sales of Chinese-developed games reaching $9.501 billion, an 11.07% increase year-on-year [6][21]

证券日报网讯 12月16日晚间，凯普生物发布公告称，广东凯普生物科技股份有限公司近日完成了全资 子公司北京凯普康和互联网医院有限公司的工商设立登记并取得由北京市昌平区市场监督管理局核发的 《营业执照》。 （编辑 姚尧） ...

风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 12月16日，港股通生物科技ETF（159102）跌1.81%，成交额2222.11万元。当日份额增加150.00万份， 最新份额为8.58亿份，近20个交易日份额减少550.00万份。最新资产净值计算值为7.03亿元。 港股通生物科技ETF（159102）业绩比较基准为恒生生物科技指数收益率(经汇率调整)，管理人为华安 基金管理有限公司，基金经理为倪斌，成立（2025-09-05）以来回报为-18.03%，近一个月回报 为-11.11%。 来源：新浪基金∞工作室 ...

Group 1 - The pharmaceutical sector experienced narrow fluctuations, with the Hang Seng Innovative Drug Index down by 0.1%, while other indices such as the CSI Hong Kong Pharmaceutical and Health Comprehensive Index and the CSI Biotech Theme Index both rose by 0.1% [1] - The CSI Innovative Drug Industry Index saw an increase of 0.2%, indicating a positive trend in innovative drug stocks [1] - Recent fund inflows into ETFs indicate continued investment interest, with the Hang Seng Innovative Drug ETF and Pharmaceutical ETF receiving net inflows of 97 million yuan and 370 million yuan respectively over the past week [1] Group 2 - The index focuses on leading stocks in the Hong Kong medical and health industry, comprising 50 stocks from medical devices, biopharmaceuticals, chemical drugs, and other pharmaceutical sectors [3] - The Innovative Drug ETF tracks the CSI Innovative Drug Industry Index, which includes no more than 50 companies primarily engaged in innovative drug research and development [4][5] - The Biotech ETF tracks the CSI Biotech Theme Index, which consists of up to 50 companies involved in gene diagnostics, biopharmaceuticals, blood products, and other human biotechnology [6][8] Group 3 - The CSI Biotech Theme Index recorded a slight increase of 0.1% at midday [7] - The CSI Pharmaceutical and Health Industry Index, which includes companies from the CSI 300 Index in the pharmaceutical sector, also rose by 0.1% [12][13]

天眼查App显示，近日，山东肥田乐生物科技发展有限公司成立，法定代表人为满孝究，注册资本8000 万人民币，经营范围为一般项目：生物饲料研发；生物有机肥料研发；技术服务、技术开发、技术咨 询、技术交流、技术转让、技术推广；肥料销售；农作物秸秆处理及加工利用服务。（除依法须经批准 的项目外，凭营业执照依法自主开展经营活动）许可项目：肥料生产。（依法须经批准的项目，经相关 部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）。 ...

天眼查App显示，近日，江西嘉盛生物科技有限公司成立，法定代表人为郜文宇，注册资本10万人民 币，经营范围为许可项目：农药批发，农药零售（依法须经批准的项目，经相关部门批准后在许可有效 期内方可开展经营活动，具体经营项目和许可期限以相关部门批准文件或许可证件为准）一般项目：技 术服务、技术开发、技术咨询、技术交流、技术转让、技术推广，生物农药技术研发，农副产品销售， 化肥销售，肥料销售，五金产品批发，五金产品零售，农用薄膜销售，机械设备销售，农、林、牧、 副、渔业专业机械的销售，农林牧副渔业专业机械的安装、维修（除依法须经批准的项目外，凭营业执 照依法自主开展经营活动）。 ...

经济观察网证监会网站显示，成都迈科康生物科技股份有限公司2025年12月17日向四川证监局办理辅导 备案登记，辅导机构为中国国际金融股份有限公司。 ...